| Course | PHLT 8074 Environmental and Occupational Epidemiology |
|---|---|
| Week | Week 6 |
| Paper type | Peer reply |
| Length | About 400 words, 3 pages |
| Format | Discussion reply, APA 7 citations |
| School | Walden University |
| Program | PhD in Public Health |
| Updated | October 2026 |
Free sample paper for PHLT 8074 Week 6
Week 6 Discussion: Peer Reply
The Right Compound, the Wrong Years: A Peer Reply on Using Serum Organochlorine Levels Drawn at Diagnosis as the Exposure Marker in a Parkinson's Disease Case-Control Study
Reply to Jordan
Jordan, your proposal to measure a persistent organochlorine pesticide in serum as the exposure marker for the valley study has a real strength, and I want to start there. Because these compounds are stored in fat and leave the body slowly, a single measurement reflects years of past exposure rather than the last few days, which is more than any short-lived herbicide metabolite can offer. That makes the idea attractive for a disease thought to develop over decades.
My concern is the window. A sample drawn at diagnosis measures what remains in the body now, and two things shape that level besides the exposure you want to capture. The first is the years just before diagnosis, which for Parkinson's disease often include a long prodromal period with subtle changes such as loss of smell, constipation and sleep disturbance (Berg et al., 2015). Weight loss is also common as the disease develops. When fat stores shrink, lipophilic compounds are released into the blood, so a case may show a higher serum level because of the illness itself, not because of greater past exposure.
Lipid adjustment does not solve this. Schisterman et al. (2005) showed that common ways of adjusting serum levels for blood lipids can introduce bias of their own, depending on how lipids relate to both the exposure and the disease. Adjusting for serum lipids on the day of sampling does not correct for years of changing body fat.
The second issue is that serum at diagnosis reflects decades of elimination as well as intake, and elimination rates differ between people. Two participants with identical past exposure could have quite different levels today.
Studies that have used serum markers well drew blood long before diagnosis. Weisskopf et al. (2010) analyzed serum stored from the late 1960s and early 1970s in a Finnish cohort and compared people who later developed Parkinson's disease with controls, so the sample predated the illness by many years.
Would it be possible to find stored samples, perhaps from a blood bank or an earlier health survey in the valley? If not, would you consider using serum only as a secondary check on the interview among controls, where illness cannot affect the level?
References
Berg, D., Postuma, R. B., Adler, C. H., Bloem, B. R., Chan, P., Dubois, B., Gasser, T., Goetz, C. G., Halliday, G., Joseph, L., Lang, A. E., Liepelt-Scarfone, I., Litvan, I., Marek, K., Obeso, J., Oertel, W., Olanow, C. W., Poewe, W., Stern, M., & Deuschl, G. (2015). MDS research criteria for prodromal Parkinson's disease. Movement Disorders, 30(12), 1600-1611. https://doi.org/10.1002/mds.26431
Schisterman, E. F., Whitcomb, B. W., Buck Louis, G. M., & Louis, T. A. (2005). Lipid adjustment in the analysis of environmental contaminants and human health risks. Environmental Health Perspectives, 113(7), 853-857. https://doi.org/10.1289/ehp.7640
Weisskopf, M. G., Knekt, P., O'Reilly, E. J., Lyytinen, J., Reunanen, A., Laden, F., Altshul, L., & Ascherio, A. (2010). Persistent organochlorine pesticides in serum and risk of Parkinson disease. Neurology, 74(13), 1055-1061. https://doi.org/10.1212/WNL.0b013e3181d76a93
What the PHLT 8074 Week 6 instructions ask for
The sixth week's discussion typically asks students to respond to a classmate's proposed exposure measure with a constructive critique. Faculty expect the reply to identify the measure's genuine strengths before raising concerns, to focus on the most important problem rather than listing many, and to support the critique with evidence. For biomarkers, the time window a measurement reflects and the ways disease or treatment can alter levels are central questions. Suggesting feasible alternatives turns criticism into help. A reply of about 400 words, backed by a few scholarly sources and closing on a genuine question for the classmate, is typical. A collegial tone is expected throughout. Citing a study that used stored samples is a useful way to show the alternative is practical.
How this PHLT 8074 Week 6 example is built
The reply opens by naming the strength of a persistent marker, its long integration of past exposure. A paragraph then raises the timing problem, citing research criteria for prodromal Parkinson's disease and explaining how weight loss can raise serum levels of lipophilic compounds. The next paragraph explains why lipid adjustment does not solve this, citing a study showing that adjustment methods can introduce bias. A short paragraph adds that individual differences in elimination make levels at diagnosis an imperfect record of intake. A paragraph cites a Finnish nested case-control study that used serum stored decades earlier. The reply ends with two questions, about stored samples and about using serum only among controls as a secondary check.
Where the marks sit in the PHLT 8074 Week 6 rubric
Peer replies are scored on accuracy, focus and helpfulness. The sample earns accuracy credit by correctly explaining why persistent compounds integrate exposure and how disease-related weight loss and lipid adjustment complicate interpretation. Focus comes from concentrating on one problem, the time window, rather than listing every limitation of biomarkers. Helpfulness is shown in the alternatives offered, stored samples or a controls-only check, which give the classmate a path forward. Opening with the measure's strength sets a collegial tone that rubrics reward under professional communication. Supporting each claim with a source, keeping within the expected length and ending with genuine questions complete the criteria. Brevity counts too, since a reply that tries to fix everything usually fixes nothing.
Common PHLT 8074 Week 6 mistakes, and how to avoid them
Biomarker critiques often dismiss a measure as unreliable without explaining why. Be specific about the time window: what period does the level reflect, and could the disease itself have changed it? For persistent compounds, weight loss and body fat changes are common confounders of timing. Avoid overstating what lipid adjustment can do. Another weakness is criticizing without offering alternatives; suggest a feasible option, such as stored samples or a restricted use of the marker. Acknowledge what the classmate got right first, since persistent markers do integrate exposure. Keep the reply focused on one problem and end with a question. Send us your classmate's post and we will draft a free custom reply to it.
Get a PHLT 8074 Week 6 example written to your instructions
Paste the post you are answering and add the Week 6 prompt and rubric. The reply concedes what the chosen marker does well, identifies the window it actually reflects, and explains how the outcome or other factors could shape its level, ending with a better-timed alternative. First reply free; back in 24-48 hours.
More PHLT 8074 papers and PhD in Public Health samples
- PHLT 8074 Week 1: Exposure Framing Discussion Post
- PHLT 8074 Week 2: Exposure Methods Survey
- PHLT 8074 Week 3: Herbicide Exposure Definition Paper
- PHLT 8074 Week 4: Exposure Assessment Critique
- PHLT 8074 Week 5: Crop-Exposure Matrix Analysis
- PHLT 8074 Week 7: Exposure Metric Comparison Paper
- PHLT 8074 Week 8: Exposure Latency Analysis Paper
- PHLT 8074 Week 9: Healthy Worker Comparison Paper
- PHLT 8074 Week 10: Exposure Assessment Plan Paper
- PHLT 8074 Week 11: Exposure Metric Defense Paper
- PHLT 8072 Week 6: Hepatitis C Chain Peer Critique
- PHLT 8068 Week 6: Results Chapter Draft
- PHLT 8066 Week 6: Literature Review Reduction
- PHLT 8064 Week 6: Measurement Memo
PHLT 8074 Week 6 questions, answered
Is the classmate post a real one?
The post, the valley study and its participants are inventions for this page. The choice of an organochlorine marker was made because it illustrates a long window distorted by illness, a pattern discussed in the biomonitoring literature. No serum level or finding appears. Paste the real post you are answering, and the custom reply engages its exact marker and wording.
Where can I find a free PHLT 8074 Week 6 sample paper?
You can read the complete Week 6 peer reply here, critiquing the timing of a serum organochlorine marker drawn at diagnosis for a composite Parkinson's disease study and suggesting alternatives. The cited studies are real.
Why can a persistent compound's serum level rise because of illness?
These compounds are stored in body fat. When a person loses weight, as often happens as Parkinson's disease develops, stored compound is released into the blood, so serum levels can rise without any new exposure.
Does lipid adjustment fix the timing problem?
No. Adjusting for blood lipids on the day of sampling corrects for circulating fat at that moment, not for years of changing body fat, and research has shown that common adjustment methods can themselves introduce bias.
What would a better use of serum look like?
Measuring serum stored long before diagnosis, as a Finnish study did with samples from decades earlier, avoids the prodromal window. Without stored samples, using serum only among controls as a check on interview reports avoids illness affecting the level.